|
Wednesday, November 15, 2017
Print Current Day:
 |
|
| SESSION 23 SCHEDULE | |
|
Wednesday
SESSION 23:
OCCLUSIVE DISEASE MANAGEMENT – HOT TOPICS, NEW DEVELOPMENTS AND IMPORTANT GENERALITIES
|
|
| x | |
| 6:40 AM - 6:45 AM | Role And Comparative Value Of All Access Sites And Routes For Lower Extremity Endovascular Treatments: Which Are Best And When |
|
Presenter(s):Jihad A. Mustapha, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 6:46 AM - 6:51 AM | 12 Commandments For Successful BTK Intervention In Chronic Limb Threatening Ischemia (CLTI) Patients: Including Technical Tips For Antegrade Femoral Artery Puncture |
|
Presenter(s):Ali Amin, MD, RVT, FACS, FACC Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 6:52 AM - 6:57 AM | Role Of BMSs, Supera Stents, DCBs, DESs And Atherectomy For Various SFA/Pop Lesions: What Works For Which Lesion And What Is The Evidence |
|
Presenter(s):Brian G. DeRubertis, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 6:58 AM - 7:03 AM | Relationship Between Vessel Size And Clinical Outcomes Of Endovascular Treatments Of Fem-Pop Lesions: Small Diameter Arteries Have Worse Outcomes |
|
Presenter(s):Seiichi Hiramori, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 7:04 AM - 7:09 AM | Differing Patterns Of Restenosis With Various Endovascular Treatments: What Are The Implications For Determining The Best Treatment |
|
Presenter(s):Lawrence A. Garcia, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 7:10 AM - 7:15 AM | New Global Multidisciplinary Guideline For Chronic Limb Threatening Ischemia (CLTI): A Better Evidence-Based Framework For Staging Decision Making, Treating And Reporting |
|
Presenter(s):Michael S. Conte, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 7:16 AM - 7:21 AM | DEBATE: Endovascular Treatments Should Be The First Option For Most Patients With CLTI – Today And In The Future |
|
Presenter(s):Peter A. Schneider, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 7:22 AM - 7:27 AM | DEBATE: Not So: Open Procedures Should Be The First Therapeutic Option In Many CLTI Patients: What Is The Percentage Today: What Will It Be In 5 Years As Techniques Improve |
|
Presenter(s):Joseph L. Mills, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 7:28 AM - 7:33 AM | What Are The Many Variables In Drug Eluting Technologies Which May Influence Their Ability To Prevent Restenosis: Where Are They Today And Where Are They Going |
|
Presenter(s):William A. Gray, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 7:34 AM - 7:39 AM | Tips And Tricks For Plain Old Balloon Angioplasty (POBA) Of Infrapopliteal Artery Lesions: Details Matter And How To Do It Optimally |
|
Presenter(s):Roberto Ferraresi, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 7:40 AM - 7:45 AM | Panel Discussion |
| END OF SESSION 23 | |
| SESSION 24 SCHEDULE | |
|
Wednesday
SESSION 24:
MORE ON LOWER EXTREMITY OCCLUSIVE DISEASE – NEW DEVELOPMENTS AND HOT TOPICS RELATING TO STENTS
|
|
| x | |
| 7:46 AM - 7:51 AM | When Are Stents Required In The Era Of DCBs: Is It Best To Leave No Metal Behind |
|
Presenter(s):Koen Deloose, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 7:52 AM - 7:57 AM | Paradigm For Optimal Treatment Of Various Types Of SFA-Pop Occlusive Disease: Which Treatment For Which Lesion: Role Of Multiple Stents And Zilver PTX DESs (Cook) For Long Lesions |
|
Presenter(s):Gary M. Ansel, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 7:58 AM - 8:03 AM | Overview Of Stents For SFA-Pop Lesions: Which Is Best And When: Value Of Local Adventitial Anesthesia And The Presto Technique To Assure Optimal Supera (Abbott) Stent Delivery |
|
Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 8:04 AM - 8:09 AM | Combination Therapy For The SFA: The Evidence For Stent And DCB Choice In This Exciting New Space |
|
Presenter(s):Ramon L. Varcoe, MBBS, MS, PhD, FRACS Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 8:10 AM - 8:15 AM | Comparison Of BMSs vs. DESs For SFA Lesions: Results Of The BATTLE RCT |
|
Presenter(s):Yann Gouëffic, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 8:16 AM - 8:21 AM | Update On New Developments With The Zilver PTX DES (Cook) For SFA-Pop Lesions: Its Effectiveness Is Maintained In Longer Lesions; Patients With Poor Run-Off, Diabetes And Chronic Renal Failure; And Asian Patient Groups |
|
Presenter(s):Michael D. Dake, MD / Hiroyoshi Yokoi, MD / Kimihiro Komori, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 8:22 AM - 8:27 AM | IMPERIAL RCT Study Design Comparing Eluvia DESs (Boston Scientific) vs. Zilver PTX DESs (Cook) For The Treatment Of SFA-Pop Lesions |
|
Presenter(s):William A. Gray, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 8:28 AM - 8:33 AM | 3-Year Results Of The Eluvia DES (Boston Scientific) Shows Maintained Safety And Efficacy In The MAJESTIC RCT With Fem-Pop Lesions: Advantages Of This DES And Why It Is A Better Option Than DCBs For These Lesions |
|
Presenter(s):Stefan Müller-Hülsbeck, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 8:34 AM - 8:39 AM | Update On 3-Year Experience With The Absorb Everolimus Drug Eluting Bioresorbable Stent (BRS) From Abbott For BTK Lesions: Promising Results Beyond 2 Years And Future Prospects |
|
Presenter(s):Ramon L. Varcoe, MBBS, MS, PhD, FRACS Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 8:40 AM - 8:45 AM | Advantages Of The Supera Interwoven Biomimetic Stent(Abbott) For Treating Fem-Pop Lesions With Good 5-Year Primary Patency Even With Long And Calcified Lesions |
|
Presenter(s):Peter C.J. Goverde, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 8:46 AM - 8:51 AM | Current Needs And Solutions In The Treatment Of Severe CLTI (Rutherford 5 And 6) Due To Occlusive Lesions In The Thigh, Leg And Foot: Value Of The Supera Interwoven Stent (Abbott) And The Absorb Drug Eluting BRS (Abbott) |
|
Presenter(s):Steven Kum, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 8:52 AM - 8:57 AM | Panel Discussion |
| END OF SESSION 24 | |
| SESSION 25 SCHEDULE | |
|
Wednesday
SESSION 25:
MORE ON COMPLEX LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENT – LITHOPLASTY, ATHERECTOMY, TREATMENT FOR CALCIFICATION AND COMBINATIONS OF TREATMENT
|
|
| x | |
| 8:58 AM - 9:03 AM | Shockwave Lithoplasty - Indications And Results: Use In Combination With DCBs And Other Treatments |
|
Presenter(s):Gunnar Tepe, MD / Andrew Holden, MBChB / Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:04 AM - 9:09 AM | How To Prep Vessels For Endovascular Treatments With BMSs, DESs, DCBs: Value Of Prolonged And High Pressure Balloon Inflation, Scoring Balloons And Atherectomy |
|
Presenter(s):Erwin Blessing, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:10 AM - 9:15 AM | Vessel Prep May Cause Increased Distal Embolization And Be Harmful: How To Manage This Problem |
|
Presenter(s):Mark W. Mewissen, MD, RVT Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:16 AM - 9:21 AM | Atherectomy For Intermittent Claudication From Infrainguinal Occlusive Lesions Results In Worse Outcomes Than The Natural History Of The Disease: From Medicare Data |
|
Presenter(s):Dipankar Mukherjee, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:22 AM - 9:27 AM | Zilver PTX DES Stent (Cook) Treatment vs. Prosthetic Open Bypass For TASC C/D Lesions: Results Of The ZILVERPASS RCT |
|
Presenter(s):Patrick Peeters, MD / Koen Deloose, MD / Marc Bosiers, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:28 AM - 9:33 AM | What Is The Value Of Adding A DCB To A BMS To Treat Fem-Pop Occlusive Disease: It Depends On The DCB Used (Passeo-18 Lux DCB [Biotronik]): 1-Year Results Of The BIOLUX 4 EVER Trial |
|
Presenter(s):Koen Deloose, MD / Marc Bosiers, MD / Patrick Peeters, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:34 AM - 9:39 AM | Value Of Lesion Preparation With Directional Atherectomy In Improving Outcomes Of DCB Treatment: From The DEFINITIVE AR Trial |
|
Presenter(s):Thomas Zeller, MD / Gunnar Tepe, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:40 AM - 9:45 AM | Comparison Of DCBs (In.Pact) vs. DESs (Zilver PTX) 1-Year Results With Treatment Of TASC A/B And C/D Lesions: From The DRASTICO Trial Of Fem-Pop Lesions |
|
Presenter(s):Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:46 AM - 9:51 AM | All Drug Eluting Stents Are Not The Same For The Treatment Of Infrapopliteal Arteries: Results From An Updated Meta-Analysis Of RCTs |
|
Presenter(s):Ramon L. Varcoe, MBBS, MS, PhD, FRACS Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:52 AM - 9:57 AM | Character And Localization Of Arterial Calcification: What Significance Does It Have For Producing Ischemia And Making Endovascular Treatments Difficult |
|
Presenter(s):Renu Virmani, MD / Aloke Finn, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:58 AM - 10:03 AM | Calcified Arteries Are Hard To Clamp And Sew In Bypass Surgery: Technical Tips And Tricks To Deal With These Problems Successfully |
|
Presenter(s):Enrico Ascher, MD / Frank J. Veith, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:04 AM - 10:10 AM | Panel Discussion |
| 10:10 AM - 10:20 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 25 | |
| SESSION 26 SCHEDULE | |
|
Wednesday
SESSION 26:
MORE ON LOWER EXTREMITY OCCLUSIVE DISEASE: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs), OTHER DEVICES AND BELOW-THE-KNEE (BTK) DISEASE
|
|
| x | |
| 10:20 AM - 10:25 AM | Current Status Of All DCBs For Fem-Pop Lesions: RCTs And Other Evidence: Comparative Performance: All DCBs Are Not Equal |
|
Presenter(s):John R. Laird, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:26 AM - 10:31 AM | With DCBs For CLTI Distal Drug Migration May Adversely Affect Wound Healing: Has It Ever Happened |
|
Presenter(s):Ignacio Escotto, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:32 AM - 10:37 AM | Evolution Of Optimal DCB Technology: Where Is It Currently And Where Can It Go |
|
Presenter(s):William A. Gray, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:38 AM - 10:43 AM | Current Value Of DCBs For Fem-Pop And BTK Lesions: What Are The Prospects For Improvement In The Future: New 1-Year Chinese In.Pact Results With SFA Lesion |
|
Presenter(s):Gunnar Tepe, MD / Zhong Chen, MD, Professor Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:44 AM - 10:49 AM | How Well Will DCBs Work For Calcified And Long Lesions; For Total Occlusions: Will Adjuncts And Improvements Help |
|
Presenter(s):Fabrizio Fanelli, MD, EBIR Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:50 AM - 10:55 AM | 4-Year Results Of The IN.PACT SFA RCT Comparing The In.Pact Admiral DCB (Medtronic) vs. POBA In Fem-Pop Lesions: The Patency Benefits Persist And With Various Lesions In Different Patient Groups |
|
Presenter(s):Peter A. Schneider, MD / John R. Laird, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:56 AM - 11:01 AM | Real World Value Of The In.Pact Admiral DCB (Medtronic) For Fem-Pop Lesions: From The In.Pact Global Registry: What Else Does It Tell Us |
|
Presenter(s):Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:02 AM - 11:07 AM | Panel Discussion |
| Moderator(s): John R. Laird, MD / Antonio Micari, MD, PhD | |
| 11:08 AM - 11:13 AM | 2-Year Value Of The Lutonix DCB (Bard) For the Treatment Of Fem-Pop Occlusive Lesions In A RCT vs. POBA: Do The Benefits Persist And What Are They In Long Complex Lesions |
|
Presenter(s):Dierk Scheinert, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:14 AM - 11:19 AM | Safety And Benefits Of The Lutonix DCB (Bard) For The Treatment Of BTK And Infrapopliteal Artery Lesions: > 1-Year Results From A Global Registry |
|
Presenter(s):Michael K.W. Lichtenberg, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:20 AM - 11:25 AM | 1-Year Results With The Ranger DCB (Boston Scientific) For The Treatment Of Fem-Pop Lesions: Equivalent Benefits In Diabetic Patients And 12-Month All Comer Registry Data |
|
Presenter(s):Dierk Scheinert, MD / Michael K.W. Lichtenberg, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:26 AM - 11:31 AM | Update On The > 1-Year Results With The Stellarex DCB (Spectranetics) For Fem-Pop Lesions: From The European And US ILLUMENATE RCTs vs. POBA: It Is Effective With Long Complex Occlusive Lesions And In Diabetics |
|
Presenter(s):Sean P. Lyden, MD / Stefan Müller-Hülsbeck, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:32 AM - 11:37 AM | Comparison Of 4 Different DCBs (Including A New One From Acotec) In BTK And Infrapopliteal Arteries: Why Results Have Differed And What Are Prospects For DCB Benefits BTK: Insights From The ACO-ART BTK Registry |
|
Presenter(s):Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:38 AM - 11:43 AM | Will DCBs Ever Work Effectively In BTK And Crural Artery Occlusive Disease: Sizing Matters: How Can Ultrasound Help And How To Predict Performance |
|
Presenter(s):Antonio Micari, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:44 AM - 11:49 AM | Drug Coated “Low Trauma”: Chocolate Touch PTA Balloon (TriReme Medical & QT Vascular): Advantages And 1-Year Results: From The ENDURE Trial |
|
Presenter(s):Gunnar Tepe, MD / Andrew Holden, MBChB / Thomas Zeller, MD / Wei Guo, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:50 AM - 11:55 AM | DCBs And DESs Produce Equivalent Results At 2-3 Years With Short SFA Lesions But DESs Are Better For Long Lesions: From The REAL-PTX RCT |
|
Presenter(s):Dierk Scheinert, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:56 AM - 12:03 PM | Panel Discussion |
| 12:03 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 26 | |
| SESSION 27 SCHEDULE | |
|
Wednesday
SESSION 27:
MORE ABOUT CHRONIC LIMB THREATENING ISCHEMIA (CLTI); THE “NO-OPTION FOR TREATMENT” LIMB AND EXTREME LIMB SALVAGE TECHNIQUES AND RESULTS
|
|
| x | |
| 1:00 PM - 1:05 PM | Unusual Open Surgical Limb Salvage Techniques To Save Limbs Deemed “Unsalvageable”: They Often Work |
|
Presenter(s):Enrico Ascher, MD / Neal S. Cayne, MD / Frank J. Veith, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | All Patients With CLTI Should Have An Attempt At Revascularization: The Angiosome Concept Is Not Usually Helpful: Tips And Tricks For Success And Who Should Have A Primary BTK Amputation |
|
Presenter(s):Hisham Rashid, FRCS, FRCS (Gen) Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | Value Of PTFE Femoro-Tibial/Peroneal Bypasses To Salvage Limbs: Long-Term Patency Is Possible Although Redo Procedures May Be Needed |
|
Presenter(s):Carlo Pratesi, MD / Raffaele Pulli, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | PTFE Tibial And Peroneal Bypasses For Limb Salvage Are Worthwhile: Patients Having Them Have Better Short And Long-Term Cardiovascular Morbidity And Mortality (Up To 5 Years) Than Those Undergoing Amputation |
|
Presenter(s):Nicholas J. Gargiulo III, MD, RPVI, RVT, RDMS, FACS / Gregg S. Landis, MD / Neal S. Cayne, MD / Frank J. Veith, MD / Evan C. Lipsitz, MD, MBA Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | Indications And Techniques For And Midterm Results Of Below The Ankle Angioplasty For CLTI |
|
Presenter(s):Roberto Ferraresi, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 1:30 PM - 1:35 PM | Indications, Techniques And Results Of Pedal-Plantar Loop And Transcollateral Angioplasty: Tips And Tricks For Metatarsal Artery Access |
|
Presenter(s):Marco G. Manzi, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| ARTERIALIZING FOOT VEINS | |
| 1:36 PM - 1:41 PM | How To Salvage Unsalvageable Limbs By Arterializing The Venous Circulation Of The Foot By Bypasses, Etc.: Technical Steps And Long-Term Results |
|
Presenter(s):Pramook Mutirangura, FRCS (Edinburgh) Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 1:42 PM - 1:47 PM | Percutaneous Endovascular Arterialization Of Ankle And Foot Veins For End Stage No Option CLTI (The Dessert Foot) Using The Limflow System: How It Works (Video) And Results |
|
Presenter(s):Steven Kum, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 1:48 PM - 1:53 PM | The Limflow Venous Arterialization System Via Percutaneous Punctures: Technical Tips, Precautions, Hybrid Modifications And Results: How to Make It Work To Salvage The Otherwise Unsalvageable CLTI Foot |
|
Presenter(s):Roberto Ferraresi, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 1:54 PM - 2:00 PM | US Experience With The Limflow Procedure For Percutaneous Venous Arterialization For Limb Salvage |
|
Presenter(s):Daniel G. Clair, MD / Jihad A. Mustapha, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:00 PM - 2:06 PM | Panel Discussion |
| END OF SESSION 27 | |
| SESSION 28 SCHEDULE | |
|
Wednesday
SESSION 28:
NEW DEVELOPMENTS IN LOWER EXTREMITY STENT-GRAFTS, PROSTHETIC (PTFE) GRAFTS AND TREATMENT FOR IN-STENT RESTENOSIS (ISR)
|
|
| x | |
| 2:06 PM - 2:11 PM | Selective Open And Endovascular Treatment Achieves The Best Results With CLTI: Tips And Tricks To Achieve Good Distal Bypass Results And The Value Of PTFE Grafts To Crural Arteries When Vein Is Unavailable |
|
Presenter(s):Francesco Spinelli, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:12 PM - 2:17 PM | Advantages Of And Indications For The Viabahn VBX Balloon Expandable Covered Stent (Gore): Technical Tips, Limitations And Value In Treating Aorto-Iliac Disease |
|
Presenter(s):Jean Bismuth, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:18 PM - 2:23 PM | Percutaneous Transvenous Prosthetic Arterial Bypass For Long Complicated Fem-Pop Occlusions: The PQ Bypass Procedure: Concept And Technique For Performing (Video) |
|
Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD / James D. Joye, DO Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:24 PM - 2:29 PM | 1-Year Results Of The PQ Transvenous Bypass Procedure: From The Multicenter DETOUR Trial |
|
Presenter(s):Sean P. Lyden, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:30 PM - 2:35 PM | Update On Endoluminal Bypass With Viabahn Stent Grafts (Gore): How To Prevent And Treat Edge Stenosis Failures: Results Of The SUPER B RCT Comparing Endoluminal Bypasses vs. Standard Vein Bypasses For SFA Occlusions |
|
Presenter(s):Michel M.P. Reijnen, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| IN STENT RESTENOSIS (ISR) | |
| 2:36 PM - 2:41 PM | DEBATE: Long Segment SFA ISR Is Best Treated Endovascularly: What Are The Best Current Endovascular Tools |
|
Presenter(s):Craig M. Walker, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:42 PM - 2:47 PM | DEBATE: Not So: Endovascular Techniques Have Poor Results In This Setting: Open Bypass Should Be The First Invasive Option |
|
Presenter(s):Niten Singh, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:48 PM - 2:53 PM | What Is The Best Current Treatment In The US For ISR: How Can OCT Improve Outcomes |
|
Presenter(s):Todd R. Vogel, MD, MPH Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:54 PM - 2:59 PM | DCBs For ISR: Does Double Dosing Help: 2-Year Results Of The COPA CABANA Trial With The Cotavance DCB (Medrad-Bayer) |
|
Presenter(s):Gunnar Tepe, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 3:00 PM - 3:05 PM | Brachy Therapy For Severe Or Extensive ISR: It Is Still A Viable Treatment Option For A Difficult Problem: Advantages And Limitations |
|
Presenter(s):Matthew T. Menard, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 3:06 PM - 3:11 PM | Panel Discussion |
| 3:12 PM - 3:28 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 28 | |
| SESSION 29 SCHEDULE | |
|
Wednesday
SESSION 29:
NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI)
|
|
| x | |
| NEW DEVELOPMENTS RELATED TO INTERMITTENT CLAUDICATION (IC) | |
| 3:28 PM - 3:33 PM | The Financial Side Of Invasive Treatments For IC |
|
Presenter(s):Robert M. Zwolak, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 3:34 PM - 3:39 PM | Drugs And Neuromuscular Stimulation (NMES) Can Improve Walking Distance With IC: How To Do It |
|
Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 3:40 PM - 3:45 PM | Drug Eluting Devices Are The New Standard For Fem-Pop Endovascular Treatments For IC: The Timing Of Development Of Restenosis Is A Guide To Why Extended Drug Release Is Important With DESs: Which DES Has It |
|
Presenter(s):Peter A. Schneider, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 3:46 PM - 3:51 PM | How To Differentiate With Certainty Ischemic Buttock Claudication From Spinal Stenosis |
|
Presenter(s):Manju Kalra, MBBS Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 3:52 PM - 3:57 PM | RCTs Of Supervised Exercise Therapy vs. PTA For IC Due To Iliac Occlusive Disease: What Do The CLEVER And The Newly Finished SUPER RCTs Tell Us |
|
Presenter(s):Mark J.W. Koelemay, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 3:58 PM - 4:03 PM | What Is Venous Claudication: How Should It Be Diagnosed And Treated |
|
Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| PROGRESS IN THE TREATMENT OF ACUTE LIMB ISCHEMIA (ALI) | |
| 4:04 PM - 4:09 PM | Endovascular Treatment Of ALI Is Better Than Open Surgical Treatment: When Is It Not: From A Nationwide Swedish Study |
|
Presenter(s):Martin Bjorck, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 4:10 PM - 4:15 PM | Acute Limb Ischemia (ALI): What Is The Best Current Treatment Approach: Predictors Of Limb Loss And Salvage In This Setting: When Is Open Treatment The Best Option |
|
Presenter(s):Niten Singh, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 4:16 PM - 4:21 PM | Large Caliber Percutaneous Vacuum Assisted Thrombectomy In ALI: How Does It Work: Benefits And Limitations: Will It Replace Thrombolysis And Open Surgery Michele Rossi, MD |
|
Presenter(s):Michele Rossi, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 4:22 PM - 4:27 PM | New Tips And Tricks For Managing ALI: Value Of Duplex Ultrasound In This Setting |
|
Presenter(s):Michael H. Wholey, MD, MBA Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 4:28 PM - 4:37 PM | Panel Discussion |
| END OF SESSION 29 | |
| SESSION 30 SCHEDULE | |
|
Wednesday
SESSION 30:
IMPORTANCE OF FOOT ARTERIES AND PERFUSION IN CLTI: HOW TO ASSESS AND TREAT; VALUE OF ANGIOSOMES; METHODS TO EVALUATE EFFECTIVENESS OF TREATMENT
|
|
| x | |
| 4:38 PM - 4:43 PM | Anatomical Variability And Pathology Of Foot Arteries: When And How To Treat And Results: Value Of Angiosomes: Is There A Role For Bypass |
|
Presenter(s):Roberto Ferraresi, MD / Marco G. Manzi, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 4:44 PM - 4:49 PM | DEBATE: The Angiosome Concept Has Little Value: Never Deny A Patient With CLTI A Revascularization For Limb Salvage Based On It |
|
Presenter(s):Frank E.G. Vermassen, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 4:50 PM - 4:55 PM | DEBATE: When Does The Angiosome Concept Make A Difference And When Not: What Explains Discordant Results And Opinions |
|
Presenter(s):Richard F. Neville, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 4:56 PM - 5:01 PM | When Does The Angiosome Concept Matter: With Open Surgery For Limb Salvage; For Endovascular Treatments For Limb Salvage: How Does Indocyanine Green Fluorescence Imaging (IGFI) Help |
|
Presenter(s):Maarit Venermo, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:02 PM - 5:07 PM | Effective Non-Invasive Treatment Of CLTI By The Art-Assist Sequential Compression Device: How Does It Work By Improving The Capillary Circulation: Indications And Results |
|
Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:08 PM - 5:13 PM | 3-Year Results Of The SPINACH Trial Show What Factors Are Important For Selecting Open Or Endovascular Treatments For CLTI |
|
Presenter(s):Nobuyoshi Azuma, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:14 PM - 5:19 PM | Treatment Strategy For CLTI Should Depend On The Degree Of Ischemia And The Extent Of The Gangrene: This May Explain Different Opinions On Angiosomes |
|
Presenter(s):Joseph L. Mills, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| NON-INVASIVE IMAGING | |
| 5:20 PM - 5:25 PM | Modalities To Determine The Adequacy Of Pedal Revascularization In CLTI |
|
Presenter(s):Krishna J. Rocha-Singh, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:26 PM - 5:31 PM | DZAM: A Software Based System For Assessing Foot Perfusion From Doppler Signals: How Does It Work And Advantages |
|
Presenter(s):Cynthia K. Shortell, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:32 PM - 5:37 PM | Value Of The Profusa Lumee Implantable O2 Microsensors And Indocyanine Green Angiography To Assess Foot Perfusion Before And After Treatment For CLTI |
|
Presenter(s):Miguel F. Montero-Baker, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:38 PM - 5:43 PM | 2D Perfusion Angiography To Assess The Effectiveness Of Treatments On Foot Perfusion: How To Do It And Quantitate Its Results |
|
Presenter(s):Jos C. van den Berg, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:44 PM - 5:49 PM | A New Medium To Small Vessel Embolic Device (From Shape Memory): First In Man Trial - The IMPEDE Trial |
|
Presenter(s):Andrew Holden, MBChB Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:50 PM - 5:58 PM | Panel Discussion End of Program E |
| END OF SESSION 30 | |
| SESSION 31 SCHEDULE | |
|
Wednesday
SESSION 31:
MEDICAL TREATMENTS; LIPID MANAGEMENT BY DRUGS; HEART AND CORONARY STENT RELATED TOPICS
Location: Grand Ballroom West, 3rd Floor
Moderators:Russell H. Samson, MD, RVT, FACS / Karthikeshwar Kasirajan, MD |
|
| x | |
| 6:40 AM - 6:45 AM | Value And Limitations Of Cannabis (Marijuana) In Vascular Patients: What Is The Drug’s Effect On Blood Vessels |
|
Presenter(s):Karthikeshwar Kasirajan, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 6:46 AM - 6:51 AM | How Does A Cardiology Evaluation Before Major Vascular Surgery Decrease Perioperative Myocardial Infarction Rates |
|
Presenter(s):Ashraf Mansour, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 6:52 AM - 6:57 AM | Value Of Statins, Diet, Ezetimibe And PCSK-9 Inhibitors In Vascular Patients: Update On The Importance Of LDL Cholesterol (LDL-C) Levels: How Low Should They Be Pushed: What Drugs And Dosages |
|
Presenter(s):Peter Henke, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 6:58 AM - 7:03 AM | Are LDL-C Levels And Statin Induced Decreases In LDL-C Levels Important (As In Europe) Despite AHA Guidelines: How To Treat Patients Needing Lipid Lowering Who Appear Statin Intolerant |
|
Presenter(s):Caron B. Rockman, MD / Jeffrey S. Berger, MD, MS, FAHA, FACC Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:04 AM - 7:09 AM | DEBATE: Lowering LDL-C Levels With Statins And PCSK-9 Inhibitors In Vascular And At Risk Patients Prevents Cardiovascular Events And Deaths, Is Reasonably Safe And Helps Patients To Have Longer And Better Lives |
|
Presenter(s):Ron Waksman, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:10 AM - 7:15 AM | DEBATE: Not So: Statins Are Dangerous Drugs And Lowering LDL-C Levels Does No Good And May Be Harmful |
|
Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:16 AM - 7:21 AM | Why Are PCSK-9 Inhibitors A Game-Changer For PAD Patients: Coronary Plaques Can Stabilize With Lower LDL-C Levels Produced By High Dose Statins Plus PCSK-9 Inhibitors: The GLAGOV Trial: How Low Should The LDL-C Be Lowered To |
|
Presenter(s):Ido Weinberg, MD, MSc Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:22 AM - 7:27 AM | The Less Than Stellar 3-Year Results Of The Absorb Drug Eluting Bioresorbable Stent (BRSs) (Abbott) In Coronary Lesions May Be Due To Variable And Imperfect Implantation Techniques And Sizing: Small Arteries May Be A Problem: What Is The Future For BRSs |
|
Presenter(s):Ron Waksman, MD / Gregg W. Stone, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:28 AM - 7:33 AM | Update On When If Ever After A Coronary BMS Or DES Can Vascular Surgery Safely Be Performed And How Should Antiplatelet Drugs Be Managed Perioperatively In Coronary Stent Patients |
|
Presenter(s):Caron B. Rockman, MD / Jeffrey S. Berger, MD, MS, FAHA, FACC Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:34 AM - 7:39 AM | Effect Of Frailty Assessment On Preoperative Risk Predictive Models For Various Vascular Surgical Procedures In Various Vascular Beds |
|
Presenter(s):Mohammad H. Eslami, MD, MPH Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:40 AM - 7:48 AM | Panel Discussion |
| END OF SESSION 31 | |
| SESSION 32 SCHEDULE | |
|
Wednesday
SESSION 32:
MEDICAL AND INTERVENTIONAL TREATMENT OF HYPERTENSION; REGENERATIVE TREATMENTS; STENOSIS ASSESSMENT BY FRACTIONAL FLOW RESERVE (FFR); VALUE OF FISH OILS
Location: Grand Ballroom West, 3rd Floor
Moderators:Ron Waksman, MD / Jeffrey S. Berger, MD, MS, FAHA, FACC |
|
| x | |
| 7:49 AM - 7:54 AM | Update On Recent Trials Of Drug Treatment For Control Of Hypertension: What Is Optimal Medical Treatment And What Level Of Blood Pressure Should Be Maintained In Patients |
|
Presenter(s):Natalie A. Marks, MD, RPVI, RVT, FSVM Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:55 AM - 8:00 AM | How To Manage Renal Dysfunction And Hypertension In Patients With Atherosclerotic Renal Artery Stenosis: When Is Medical Treatment Or Stenting/Bypass Indicated Despite The CORAL And ASTRAL Trials |
|
Presenter(s):Thomas A. Sos, MD / Jean-Baptiste Ricco, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 8:01 AM - 8:06 AM | Status Of Renal Denervation And Other New Invasive Catheter-Based Treatments For Drug Resistant Hypertension |
|
Presenter(s):Horst Sievert, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 8:07 AM - 8:12 AM | Endovascular Creation Of An Iliac Arterio-Venous Fistula To Treat Drug Resistant Hypertension: Rationale And Results Of The ROX Trial Of The ROX Coupler Device |
|
Presenter(s):Krishna J. Rocha-Singh, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 8:13 AM - 8:18 AM | A Promising New Device To Treat Drug Resistant Hypertension By Reshaping The Carotid Sinus And Enhancing Baroreceptor Activity: The Mobius HD Device (Vascular Dynamics): How It Works And Results From The CALM II Trial |
|
Presenter(s):Mark C. Bates, MD / Gregg W. Stone, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 8:19 AM - 8:24 AM | Stem Cell And Gene Treatment For CLTI Is Not Dead Yet: Results Of The MOBILE Trial Of Bone Marrow Aspirate Cells |
|
Presenter(s):Richard J. Powell, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 8:25 AM - 8:30 AM | Regenerative Medicine For CLTI: What Is The Future For Stem Cell Therapy In Vascular Disease: Current Highlights |
|
Presenter(s):Dong-ik Kim, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 8:31 AM - 8:36 AM | Image Based Coronary Computational Flow Analysis (FFRct) Can Reduce Perioperative Myocardial Infarctions And Improve Outcomes In Vascular Patients With AAAs And Occlusive Disease: How Does It Work |
|
Presenter(s):Christopher K. Zarins, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 8:37 AM - 8:42 AM | Fish Oil (Omega 3) May Be Good For The Heart But Bad For AAA Development: Why This Is So |
|
Presenter(s):Jes S. Lindholt, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 8:43 AM - 8:48 AM | Compensatory Arterial Enlargement In Diabetics: Mechanism And Significance For Treatments |
|
Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 8:49 AM - 8:55 AM | Panel Discussion |
| END OF SESSION 32 | |
| SESSION 33 SCHEDULE | |
|
Wednesday
SESSION 33:
ENDOLEAKS AND ENDOTENSION: THEIR NATURAL HISTORY AND TREATMENT
|
|
| x | |
| 8:56 AM - 9:01 AM | The Underlying Mechanism Of Type 2 Endoleaks Associated With Sac Enlargement: What Is Its Impact On How They Should Be Diagnosed And Treated: Type 2 Endoleaks Can Be Dangerous |
|
Presenter(s):Michel Makaroun, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 9:02 AM - 9:07 AM | DEBATE: Type 2 Endoleaks With AAA Sac Enlargement Can Be Dangerous And Should Be Treated: What Is The Best Treatment Method |
|
Presenter(s):Stephan Haulon, MD / Jean-Pierre Becquemin, MD, FRCS Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 9:08 AM - 9:13 AM | DEBATE: Not So: Type 2 Endoleaks With Sac Growth Should Rarely Be Treated: They Infrequently Lead To Rupture: And Treatment Is More Dangerous Than The Rupture Risk |
|
Presenter(s):Hence J.M. Verhagen, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 9:14 AM - 9:19 AM | What Should Be Done When An AAA Sac Enlarges After EVAR: What Should Be Done Diagnostically And For Treatment: Is Endotension Without An Endoleak Real |
|
Presenter(s):Frans L. Moll, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 9:20 AM - 9:25 AM | Present Status Of Endotension: What Mimics It: When Is It Real: What Causes It And What To Do About It |
|
Presenter(s):Luis A. Sanchez, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 9:26 AM - 9:31 AM | How Increasing Intrasac Pressure Within AAAs Can Eliminate Endoleaks: How To Do It And Does It Work |
|
Presenter(s):David H. Deaton, MD, FACS Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 9:32 AM - 9:37 AM | With Type 1A Endoleaks After EVAR The Type Of The Original Endograft Influences The Secondary Repair Technique: When Are Cuffs, Chimney Or Sandwich Grafts The Best Approach: A Classification System Of EVAR Failures To Direct Secondary Treatment |
|
Presenter(s):Claude Mialhe, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 9:38 AM - 9:43 AM | Value Of Preliminary Selective Lumbar And Inferior Mesenteric Artery Embolization To Prevent Type 2 Endoleaks After EVAR: When Is It Indicated, Risks And 3-Year Results |
|
Presenter(s):Daniela Branzan, MD / Andrej Schmidt, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 9:44 AM - 9:49 AM | Technique And Value Of Endoleak Treatment With Microcatheters: Value Of And Technique For Transgluteal Artery And Transcaval Approaches |
|
Presenter(s):Michele Rossi, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 9:50 AM - 9:55 AM | Perigraft Sac Embolization To Treat Difficult Type 2 And Other Hard-To-Treat Endoleaks: Technical Tips And Results |
|
Presenter(s):William J. Quinones-Baldrich, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 9:56 AM - 10:02 AM | Panel Discussion |
| 10:03 AM - 10:15 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 33 | |
| SESSION 34 SCHEDULE | |
|
Wednesday
SESSION 34:
TRIBUTES TO VASCULAR SURGERY GREATS; ISSUES RELATED TO HISTORY, ETHICS, INNOVATION, VASCULAR SURGERY LEADERSHIP, PRACTICE PROBLEMS AND THEIR SOLUTION
|
|
| x | |
| TRIBUTES TO GIANTS | |
| 10:15 AM - 10:20 AM | A Tribute To Richard F. (Dick) Kempczinski (1940-2017) |
|
Presenter(s):Jerry Goldstone, MD, FACS, FRCSEd Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 10:21 AM - 10:26 AM | A Tribute To Edward B. (Ted) Diethrich (1935-2017) |
|
Presenter(s):Ali F. AbuRahma, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 10:27 AM - 10:32 AM | A Tribute To Clifford J. (Cliff) Buckley (1936 - 2017) |
|
Presenter(s):Frank J. Veith, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| NEW CONCEPT | |
| 10:33 AM - 10:38 AM | New Concept For The Linkage Between Chemotherapy And Strokes: The Edgar Allen Poe Effect |
|
Presenter(s):Emmanuel M. Houdart, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| VASCULAR SURGERY LEADERSHIP | |
| 10:39 AM - 10:44 AM | Strategies To Facilitate Vascular Surgeons Maintaining A Leadership Position In The Care Of Vascular Patients |
|
Presenter(s):Scott L. Stevens, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 10:45 AM - 10:50 AM | How To Maintain Proficiency In Open And Endovascular Procedures |
|
Presenter(s):Jose Fernandes e Fernandes, MD, PhD, FRCS (Eng), FACS, FESC, FEBVS Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 10:51 AM - 10:56 AM | Increasing Importance And Influence Of Women In Vascular Surgery: Is The Endovascular Revolution Partly Responsible |
|
Presenter(s):Rebeca Reachi Lugo, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 10:57 AM - 11:02 AM | Bitter Lessons Learned From A Vascular Surgeon Inventor About Patents, Big Companies And Lawyers: MD Inventors Are Often Fleeced |
|
Presenter(s):Juan C. Parodi, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 11:03 AM - 11:08 AM | Panel Discussion |
| Moderator(s): Cynthia K. Shortell, MD / R. Clement Darling III, MD | |
| 11:09 AM - 11:14 AM | What Are The Causes Of “Burn Out” Among Vascular Surgeons And Other Vascular Specialists: Are Institutions, Health Care Systems Or The Affordable Care Act To Blame: What Can Be Done To Prevent And Manage It |
|
Presenter(s):Peggyann Nowak-Berguer, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 11:15 AM - 11:20 AM | How MDs Should Deal With Life’s Problems Like Drug Use, Career Dissatisfaction, Job Loss, Divorce And Depression |
|
Presenter(s):Simran B. Singh, MD, MBA Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 11:21 AM - 11:26 AM | How To Live Better As You Get Older: Good Advice For Vascular Surgeons And Vascular Specialists |
|
Presenter(s):James W. Jones, MD, PhD, MHA Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 11:27 AM - 11:32 AM | What Is The Best Master’s Degree For The Vascular Surgeon/Specialist To Get And Why: MBA, MHA, MPH |
|
Presenter(s):Robert B. McLafferty, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 11:33 AM - 11:38 AM | What Serious Complications Should Vascular Surgeons/Specialists Discuss With Patients Before A Vascular Intervention To Reach Truly Informed Consent: Results Of A Delphi Consensus Study |
|
Presenter(s):Dirk T. Ubbink, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 11:39 AM - 11:44 AM | Gender Differences In EVAR And TEVAR Outcomes: Can They Be Eliminated By Better Devices And Technique |
|
Presenter(s):Erik E. Debing, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 11:45 AM - 11:50 AM | Highlights From The Australian VERVE Symposium December 2016: EVAR At 25 Years: Where Is It Going |
|
Presenter(s):Ramon L. Varcoe, MBBS, MS, PhD, FRACS / Hence J.M. Verhagen, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 11:51 AM - 11:56 AM | The Injustice Of Honoring One Individual For A Landmark Contribution While Ignoring Others And Circumstances That Made It Possible |
|
Presenter(s):Frank J. Criado, MD, FACS, FSVM Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 11:57 AM - 12:02 PM | Panel Discussion |
| 12:02 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 34 | |
| SESSION 35 SCHEDULE | |
|
Wednesday
SESSION 35:
MORE ISSUES FOR VASCULAR SURGEONS AND VASCULAR SPECIALISTS: THE HEALTH CARE SYSTEM, WHERE IT'S GOING; REIMBURSEMENT, VASCULAR MDs’ HEALTH AND ETHICS
Location: Grand Ballroom West, 3rd Floor
Moderators:Hans-Henning Eckstein, MD, PhD / Sean P. Roddy, MD |
|
| x | |
| 1:00 PM - 1:05 PM | Drivers Of Innovation And New Developments In Medical AAA Treatments: Metformin Is The Newest Drug Of Interest |
|
Presenter(s):Ronald L. Dalman, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | The Importance Of Ethics In Vascular Surgery: How To Resolve Interspecialty Conflicts And Remove Bad Doctors With Poor Outcomes: Turf Issues Cannot Be Allowed To Trump Quality Care |
|
Presenter(s):Tej M. Singh, MD, MBA Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | Do Real Treatments Of Vascular Lesions Conform To Guidelines: What Motivates Doctors To Do Procedures: From The IDOMENEO Study |
|
Presenter(s):Sebastian E. Debus, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | Serious Causes Of Aches, Pains And Ailments To Which Vascular Surgeons And Specialists Are Vulnerable To From Their Procedures: What Can Be Done To Minimize Them Or Treat Them |
|
Presenter(s):Samuel R. Money, MD, MBA Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | Why Vascular Surgeons And Specialists Should Always Be Looking And Planning For Their Next Job: Firing Or Forced Exit Is Always A Possibility: We Should Be Ready |
|
Presenter(s):Sigrid Nikol, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 1:30 PM - 1:35 PM | Vascular Surgeons Are Essential To Our Health Care System: Why Are They Often Excluded From Administrative Decision Making And Resource Assignment |
|
Presenter(s):Jeffrey H. Hsu, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 1:36 PM - 1:41 PM | Obamacare May Not Be So Bad After All: The Maryland Experience Shows Why |
|
Presenter(s):James H. Black III, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 1:42 PM - 1:47 PM | What Factors In New Health Care Systems Affect Reimbursement: How Can These Be Modified To Improve Vascular Surgeons’ Incomes |
|
Presenter(s):Francesco A. Aiello, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 1:48 PM - 1:53 PM | Where Is Health Care Reform Going: Will MACRA Continue: What Will Happen To Vascular Surgeons’/Specialists’ Incomes |
|
Presenter(s):Timothy F. Kresowik, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 1:54 PM - 1:59 PM | What Is Going To Pay For Expensive Vascular Care As The US Shifts From Obamacare (The ACA) To Whatever Is Next: Are Alternate Payment Plans An Answer |
|
Presenter(s):Sean P. Lyden, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:00 PM - 2:05 PM | Pay For Performance (PFP) Does Not Benefit Vascular Patients: It Induces Vascular Surgeons And Specialists To Intervene On Easy Cases That Need No Procedure And To Avoid Difficult Cases That Really Need Treatment |
|
Presenter(s):James W. Jones, MD, PhD, MHA Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:06 PM - 2:12 PM | Panel Discussion |
| END OF SESSION 35 | |
| SESSION 36 SCHEDULE | |
|
Wednesday
SESSION 36:
FDA; VASCULAR SURGERY’S GOVERNING BODIES, BOARDS, RRCs, EDUCATION AND TRAINING
|
|
| x | |
| 2:13 PM - 2:18 PM | Expedited Access Pathway (EAP) To Accelerate FDA Approval Of Especially Innovative Medical Treatments Or Devices |
|
Presenter(s):Dorothy B. Abel, BSBME Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:19 PM - 2:24 PM | How Can The APDVS Help Vascular Surgery Maintain And Enhance Its Clout: The Combined Match For Vascular And Cardiac Surgery Trainees Shows That Vascular Surgery Should Be A Separate Specialty With Its Own Independent Board And RRC |
|
Presenter(s):William D. Jordan Jr., MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:25 PM - 2:30 PM | Vascular Surgeons Are Not Appropriately Valued And Compensated In Hospitals For Their Unique Consultant Services: Being A Separate Independent Specialty Would Help |
|
Presenter(s):Fred A. Weaver, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:31 PM - 2:36 PM | Heart And Vascular Centers Or Institutes Do Not Benefit Vascular Surgery: Vascular Surgery Is Often The Poor Sister: The Effort To Become A Fully Independent Specialty Should Be Revived |
|
Presenter(s):Jerry Goldstone, MD, FACS, FRCSEd Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:37 PM - 2:42 PM | Why Vascular Surgery Needs A Separate Independent Residency Review Committee (RRC-VS); The American Board Of Surgery (ABS) Needs To Support Vascular Surgery’s Independence |
|
Presenter(s):John F. Eidt, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:43 PM - 2:48 PM | Why Vascular Surgery Must Have Its Own Independent RRC And American Board Of Medical Specialties (ABMS) Approved Board: How Can The Specialty Get It |
|
Presenter(s):O. William Brown, MD, JD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:49 PM - 2:54 PM | Why Full Vascular Surgery Independence Is Justified And Badly Needed: Why Hasn’t It Happened |
|
Presenter(s):David H. Deaton, MD, FACS Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:55 PM - 3:00 PM | Why Vascular Surgery Needs Its Own Independent ABMS Approved Board And RRC-VS More Than Ever: Recent Developments And Where Is The Resistance Coming From |
|
Presenter(s):Timothy M. Sullivan, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:01 PM - 3:06 PM | Will The ABS Ever Support A Fully Independent Board Of Vascular Surgery As “A Board Down The Hall”: If Not, Why Not Since Vascular And General Surgery Are Now Different Specialties |
|
Presenter(s):Spence M. Taylor, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:07 PM - 3:12 PM | What Numbers Of Open Surgical Cases Should Be Adopted For Vascular Surgical Certification: Are They Sufficient For Competence: What Are The Solutions To This Problem |
|
Presenter(s):Ronald L. Dalman, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:13 PM - 3:18 PM | How Many 0+5 Vascular Surgery Programs Currently Exist: Is There A Demand For More: How Successful Are These Programs And How Competent Are The Finishing Trainees |
|
Presenter(s):Murray L. Shames, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:19 PM - 3:25 PM | Panel Discussion |
| 3:25 PM - 3:35 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 36 | |
| SESSION 37 SCHEDULE | |
|
Wednesday
SESSION 37:
VASCULAR CARE AND ITS VALUE; REIMBURSEMENT; VOLUME AND MALPRACTICE ISSUES
Location: Grand Ballroom West, 3rd Floor
Moderators:Robert M. Zwolak, MD, PhD / Timothy M. Sullivan, MD |
|
| x | |
| 3:35 PM - 3:40 PM | Value Of A Vascular Surgeon To The Practice Of Other Specialties And To An Institution: How Can Vascular Surgeons Be Adequately Compensated By Institutions For Their Unique And Vital Contributions |
|
Presenter(s):Richard J. Powell, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:41 PM - 3:46 PM | Disparity In Medicaid Physician Payments For Vascular Surgery |
|
Presenter(s):Jennifer L. Perri, MD, MBA / Robert M. Zwolak, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:47 PM - 3:52 PM | Outlook For Vascular Surgeons’ Incomes In A Changing Health Care Environment |
|
Presenter(s):Sean P. Roddy, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:53 PM - 3:58 PM | What Is The Best Value Care For The Treatment Of SFA Lesions: For Intermittent Claudication; For CLTI |
|
Presenter(s):Gary M. Ansel, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:59 PM - 4:04 PM | Vascular Telecare Can Expand The Reach And Effectiveness Of A Vascular Surgeon’s Or Specialist’s Practice And Benefit Patients: How To Do It And Get Paid For It |
|
Presenter(s):John (Jeb) W. Hallett, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:05 PM - 4:10 PM | Hospital Readmissions After Endovascular Treatments For CLTI Are Surprisingly Frequent: Predictors, Consequences And How To Prevent Some Of Them |
|
Presenter(s):Mehdi H. Shishehbor, DO, MPH, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:11 PM - 4:16 PM | When Are Outcomes In Vascular Treatment Related To Hospital Volumes And Surgeon Volumes; And When Are They Not |
|
Presenter(s):Marc L. Schermerhorn, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:17 PM - 4:22 PM | How Electronic Medical Records Have Increased Medical Malpractice Litigation: What Precautions Can Diminish The Problem |
|
Presenter(s):O. William Brown, MD, JD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:23 PM - 4:28 PM | Late Treatment Leads To Limb Loss With Diabetic Foot Lesions: Education Of Physicians And Patients Can Prevent Amputations |
|
Presenter(s):Oscar L. Ojeda, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:29 PM - 4:35 PM | Panel Discussion |
| END OF SESSION 37 | |
| SESSION 38 SCHEDULE | |
|
Wednesday
SESSION 38:
ISSUES WITH TRIALS; RCTs; GUIDELINES; STANDARDS; REGISTRIES; QUALITY INITIATIVES; THE SVS AND THE JVS
Location: Grand Ballroom West, 3rd Floor
Moderators:Anne L. Abbott, MD, PhD, FRACP / Joseph L. Mills, MD |
|
| x | |
| 4:36 PM - 4:41 PM | Interpreting RCTs Of AAA Or Carotid Treatments: Why And How They Can Be Misleading Or Misinterpreted |
|
Presenter(s):Thomas L. Forbes, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:42 PM - 4:47 PM | Propensity Matched Clinical Trials Have Value: But They Can Also Have Limitations And Flaws: How To Maximize Their Value |
|
Presenter(s):Charles C. Miller, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:48 PM - 4:53 PM | DEBATE: Status Of The BEST Trial – A RCT Of CLI Treatments (Endo vs. Open): Laudable But Difficult: It Will Provide Useful Information |
|
Presenter(s):Alik Farber, MD / Matthew T. Menard, MD / Kenneth Rosenfield, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:54 PM - 4:59 PM | DEBATE: The BASIL 2 And 3 Trials; RCTs Of (2) Vein Bypasses vs. Endovascular First Treatments For CLI; And (3) DCBs And DESs vs. PTA With BMS Bailout: They Will Provide Useful Information |
|
Presenter(s):Andrew W. Bradbury, MD, FRCSEd Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:00 PM - 5:05 PM | DEBATE: These Trials Will Be Fraught With Problems And May Provide Little Useful Information |
|
Presenter(s):Mehdi H. Shishehbor, DO, MPH, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:06 PM - 5:11 PM | The WIFI Grading System For CLTI Is Meaningful: WIFI Scores Correlate Well With The Risks Of Amputation And Death Following Treatment |
|
Presenter(s):Marc L. Schermerhorn, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:12 PM - 5:17 PM | How Can The WIFI Grading System Influence Patient Outcomes With CLTI |
|
Presenter(s):Robert S. Crawford, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:18 PM - 5:23 PM | Panel Discussion |
| Moderator(s): Michael S. Conte, MD / Peter Gloviczki, MD | |
| 5:24 PM - 5:29 PM | What Is The SVS/VQI/FDA TEVAR For Aortic Dissection Registry: What New And Useful Information Will It Provide |
|
Presenter(s):Richard P. Cambria, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:30 PM - 5:35 PM | What Is The International Consortium Of Vascular Registries (ICVR): What Unique And Valuable Information Can Be Learned From It |
|
Presenter(s):Jack L. Cronenwett, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:36 PM - 5:41 PM | New Reporting Standards For Lower Extremity Endovascular Treatments For Ischemia: How Will They Help Bring Order Out Of Chaos |
|
Presenter(s):Michael C. Stoner, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:42 PM - 5:47 PM | New Developments In The SVS VQI And How It Can Benefit Patients And Vascular Surgeons |
|
Presenter(s):Larry W. Kraiss, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:48 PM - 5:53 PM | Increasing Disparity Between SVS AAA Guidelines And Real World Practice For AAA Repair: The Guidelines Are No Longer Relevant: What Harm Can This Cause And What Is The Solution |
|
Presenter(s):Alan M. Dietzek, MD, RPVI, FACS Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:54 PM - 5:59 PM | New Developments With The Journal Of Vascular Surgery And How They Can Be Beneficial |
|
Presenter(s):Peter F. Lawrence, MD / Peter Gloviczki, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 6:00 PM - 6:06 PM | Panel Discussion End of Program F |
| END OF SESSION 38 | |
| SESSION 39 SCHEDULE | |
|
Wednesday
SESSION 39:
MORE TOPICS RELATED TO THE THORACIC AORTA, TEVAR, AORTIC DISSECTIONS, TAAAs AND THEIR TREATMENT
|
|
| x | |
| 6:50 AM - 6:55 AM | With Mural Thrombi In The Thoracic Aorta, When Do They Have To Be Treated Invasively: If They Do, TEVAR Is The Best Treatment: Precautions |
|
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 6:56 AM - 7:01 AM | During TEVAR For TBADs, How And Why Should The Arterial Blood Pressure Be Controlled And Manipulated |
|
Presenter(s):Cherrie Z. Abraham, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 7:02 AM - 7:07 AM | TEVAR Under Local Anesthesia: How To Do It: Advantages And Limitations |
|
Presenter(s):Zvonimir Krajcer, MD, FACC Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 7:08 AM - 7:13 AM | DEBATE: Left Subclavian Artery (LSA) Perfusion Is Critical And Should Be Maintained Whenever Possible With TEVAR |
|
Presenter(s):Daniel G. Clair, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 7:14 AM - 7:19 AM | DEBATE: No: LSA Perfusion Is Not Always Necessary With TEVAR: When May It Be Unnecessary And What Are The Risks And Downsides Of LSA Revascularization |
|
Presenter(s):Thomas S. Maldonado, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 7:20 AM - 7:25 AM | Revascularizing The LSA By In Situ Fenestration After TEVAR: How To Do It When The LSA Origin Needs To Be Covered To Extend Proximal Landing Zone Or When The LSA Is Covered Inadvertently |
|
Presenter(s):Wayne W. Zhang, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 7:26 AM - 7:31 AM | A New Non A, Non B Classification For Aortic Dissections Involving The Arch: Why Is It Better And How To Treat Such Dissections |
|
Presenter(s):Bartosz Rylski, MD, PhD / Martin Czerny, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 7:32 AM - 7:37 AM | Fate Of The Distal (Abdominal) Aorta After Endovascular Or Open Treatment Of TBADs: What Secondary Treatment May Be Required And Which Treatment Is Best |
|
Presenter(s):Geert Willem H. Schurink, MD, PhD / Michael J. Jacobs, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 7:38 AM - 7:43 AM | Open Repair Is The Best Option For Treating Visceral Segment AAAs After TEVAR For TBADs: Technique Video Showing How To Do It With A “Reversed Cactus” Branched Graft |
|
Presenter(s):Francesco Spinelli, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 7:44 AM - 7:52 AM | Panel Discussion |
| END OF SESSION 39 | |
| SESSION 40 SCHEDULE | |
|
Wednesday
SESSION 40:
TREATMENT OF LESIONS OF THE ASCENDING AORTA; THE AORTIC ARCH; PARALLEL GRAFTS; AORTIC DISSECTIONS AND RELATED TOPICS
|
|
| x | |
| 7:53 AM - 7:58 AM | Early Experience With The Gore Endograft For Treating Lesions Of The Ascending Aorta: Advantages And Limitations |
|
Presenter(s):Jean Bismuth, MD / Michael J. Reardon, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 7:59 AM - 8:04 AM | Progress In The Endovascular Treatment Of Type A Aortic Dissections |
|
Presenter(s):Carlos H. Timaran, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 8:05 AM - 8:10 AM | New Concepts And Data Regarding Frozen Elephant Trunk Procedures And The Thoraflex Graft (Vascutek/Terumo) In The Treatment Of Thoracic Aortic Disease |
|
Presenter(s):Ourania Preventza, MD / Joseph S. Coselli, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 8:11 AM - 8:16 AM | In Type A Aortic Dissection Repairs, Open Ascending Aorta Graft Replacement Alone Is Not Effective Long-Term Treatment In Most Patients: What Are The Implications |
|
Presenter(s):Götz M. Richter, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 8:17 AM - 8:22 AM | Current Status Of Brain Perfusion Adjuncts And Techniques For Open Aortic Arch Repairs |
|
Presenter(s):Lars G. Svensson, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 8:23 AM - 8:28 AM | Hybrid Procedures For Aortic Arch Lesions Are Effective And Durable: Tips And Tricks To Make Them Work Effectively |
|
Presenter(s):Colin D. Bicknell, MD, FRCS Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 8:29 AM - 8:34 AM | Chimney And Periscope Grafts To Facilitate Repair Of Aneurysms In And Near The Aortic Arch: Tips To Make Them Safe, Effective And Durable |
|
Presenter(s):Mario L. Lachat, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 8:35 AM - 8:40 AM | Value And Limitations Of Aortic Arch Chimneys With Mid And Long-Term (> 5 Years) Follow Up: How To Make Them Work |
|
Presenter(s):Nicola Mangialardi, MD / Sonia Ronchey, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 8:41 AM - 8:46 AM | How To Make Chimney And Sandwich Grafts Work For Treatment Of Aortic Arch Lesions: Technical Tips, Precautions And Midterm Results |
|
Presenter(s):Armando C. Lobato, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 8:47 AM - 8:55 AM | Panel Discussion |
| END OF SESSION 40 | |
| SESSION 41 SCHEDULE | |
|
Wednesday
SESSION 41:
NEW GRAFTS FOR TAAAs; MORE ON JUXTA- AND PARARENAL AAAs; FENESTRATED AND BRANCHED EVAR (F/B/EVAR) AND PARALLEL GRAFTS
|
|
| x | |
| 8:56 AM - 9:01 AM | The “Spider Graft”: A New Hybrid Graft For Treatment Of TAAAs: How Does It Work: Advantages And Results |
|
Presenter(s):Sebastian E. Debus, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 9:02 AM - 9:07 AM | The TAMBE Multibranched Device (Gore) For Treating TAAAs: Device Description, Advantages, Limitations And 1-Year Results |
|
Presenter(s):Mark A. Farber, MD / Michel Makaroun, MD / Gustavo S. Oderich, MD, FACS Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 9:08 AM - 9:13 AM | A New Valiant Manifold Based Device (Medtronic) With Multiple Branches For Treating TAAAs: How Does It Work And 2-Year Results |
|
Presenter(s):Patrick W. Kelly, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 9:14 AM - 9:19 AM | A “Barrel” Stent-Graft For F/B/EVAR: Device Description And How It Minimizes Aortic Coverage To Protect Against Spinal Cord Ischemia |
|
Presenter(s):Piotr M. Kasprzak, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| CHIMNEY GRAFTS FOR EVAR (CH/EVAR | |
| 9:20 AM - 9:25 AM | How To Prevent Cerebrovascular Events (Strokes And TIAs) When Using Upper Extremity Access For Ch/EVAR And F/B/EVAR: What Factors Increase Stroke Risk |
|
Presenter(s):Michel J. Bosiers, MD / Konstantinos P. Donas, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 9:26 AM - 9:31 AM | A New Classification System For Type 1A Endoleaks After Ch/EVAR: How It Can Help To Determine The Best Secondary Procedure To Fix Them |
|
Presenter(s):David J. Minion, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 9:32 AM - 9:39 AM | Panel Discussion |
| MORE ON PARALLEL GRAFTS, TAAAS AND COMPLEX AAAS | |
| Moderator(s): Benjamin W. Starnes, MD / Konstantinos P. Donas, MD | |
| 9:40 AM - 9:45 AM | Technical Tips To Successful Sandwich Graft Treatment Of TAAAs And When Is This Method The Best Treatment: Results To Date |
|
Presenter(s):Armando C. Lobato, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 9:46 AM - 9:51 AM | When Should Parallel Grafts Be The First Treatment Choice For Complex AAA Repair |
|
Presenter(s):Edward Y. Woo, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 9:52 AM - 9:57 AM | Simple Retrograde Parallel (Periscope) Grafts To Preserve Left Subclavian Artery Flow During TEVAR: How To Do It With Off-The-Shelf (OTS) Components: They Never Leak And Other Advantages |
|
Presenter(s):David J. Minion, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 9:58 AM - 10:03 AM | When Are Open Repair Or No Repair The Best Option For Some Patients With Complex And Large AAAs And Unfavorable Anatomy |
|
Presenter(s):Frank J. Criado, MD, FACS, FSVM Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 10:04 AM - 10:09 AM | What Are The Options For Treating Type 3 And Type 4 TAAAs And When Should They Be Used |
|
Presenter(s):Michel Makaroun, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 10:10 AM - 10:15 AM | 3D Printed AAA Phantoms Generated From CTAs: How They Can Facilitate Training In And Performance Of Complex AAA Repairs |
|
Presenter(s):Maciej L. Dryjski, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 10:16 AM - 10:24 AM | Panel Discussion |
| 10:24 AM - 10:40 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 41 | |
| SESSION 42 SCHEDULE | |
|
Wednesday
SESSION 42:
TREATMENT OF VISCERAL AND RENAL ANEURYSMS, COMPLEX AAAs, TAAAs AND AORTIC DISSECTIONS: MULTILAYER FLOW MODULATING (MLFM) BARE STENTS: PROS AND CONS: 15-YEAR RESULTS OF THE EVAR 2 TRIAL: FUTURE OF EVAR
|
|
| x | |
| 10:40 AM - 10:45 AM | Flow Diverting Bare Stents With And Without Coils For Treating Visceral And Renal Artery Aneurysms: Technical Tips And Results |
|
Presenter(s):Michele Rossi, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 10:46 AM - 10:51 AM | Multilayer Flow Modulating (MLFM) Bare Stents For The Treatment Of Peripheral (Iliac) And Visceral/Renal Artery Aneurysms: Do The Aneurysms Shrink In Size: Long-Term Results In 47 Patients: When Is This Treatment Preferred |
|
Presenter(s):Michel Henry, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 10:52 AM - 10:57 AM | Long-Term Results Of MLFM Bare Stents For The Treatment Of Aortic Dissection And Aortic Aneurysms: The French Multicenter Experience |
|
Presenter(s):Claude D. Vaislic, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 10:58 AM - 11:03 AM | Update On Experience Treating Aortic Dissections And Complex AAAs With MLFM Bare Stents: When Do They Work And When Don’t They |
|
Presenter(s):Victor S. Costache, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 11:04 AM - 11:09 AM | Update On The Value And Limitations Of Multilayered Uncovered And Covered Stents For Treating Aortic Aneurysms And Dissections: Indications And Results |
|
Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 11:10 AM - 11:15 AM | Effectiveness Of MLFM Bare Stents In The Treatment Of Type B Dissections And Aortic Aneurysms: Long-Term Follow-Up |
|
Presenter(s):Amira Benjelloun, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 11:16 AM - 11:21 AM | Update On Indications, Contraindications, Value And Results Of MLFM Bare Stents To Treat Various Aortic Lesions |
|
Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 11:22 AM - 11:27 AM | Why MLFM Bare Stents Are An Effective Treatment For Some Aortic Dissections: What Is The Evidence |
|
Presenter(s):Ivo Petrov, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 11:28 AM - 11:33 AM | MLFM Bare Stents Are An Effective Treatment For Some Aortic Dissections: They Preserve Branch Flow And Promote Aortic Remodeling: What Is The Evidence |
|
Presenter(s):Ralf R. Kolvenbach, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| EVAR 2 15-YEAR RESULTS AND THE FUTURE OF AAA REPAIR | |
| 11:34 AM - 11:41 AM | 15-Year Results Of The EVAR 2 Trial Comparing EVAR With Expectant Treatment In Patients “Unfit” For Open Repair: Improved Aneurysm-Related Mortality Gives Us An Ethical Dilemma |
|
Presenter(s):Roger M. Greenhalgh, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 11:42 AM - 11:49 AM | A Look At The Future Of AAA Repair: Insights And Predictions From An Aortic Surgeon At The Mid-Point Of His Career |
|
Presenter(s):Frans L. Moll, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 11:50 AM - 12:00 PM | Panel Discussion |
| 12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 42 | |
| SESSION 43 SCHEDULE | |
|
Wednesday
SESSION 43:
MORE INTERESTING TOPICS RELATED TO THE ABDOMINAL AORTA, AAAs AND EVAR
|
|
| x | |
| 1:00 PM - 1:05 PM | Variations In AAA Juxtarenal Landing Zones And Their Suitability For Various Commercial Endografts: Which Graft Is Best In Which Circumstance |
|
Presenter(s):Jan D. Blankensteijn, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | Predicting AAA Growth And Rupture With A Skin Biopsy: It Can Reflect Smooth Muscle Behavior, Genes, Biomarkers And Aortic Wall Behavior |
|
Presenter(s):Kak Khee Yeung, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | EVAR Can Be Performed Safely And Effectively In Severely Angled Necks: What Adjuncts May Be Required And When |
|
Presenter(s):Boonprasit Kritpracha, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | DEBATE: Nationwide AAA Screening Programs Are Worthwhile, Save Lives And Improve Quality Of Life (QOL) |
|
Presenter(s):Anders Wanhainen, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | DEBATE: Why Nationwide Population Based AAA Screening Programs Are Of Limited Value And A Challenge For Public Health Systems |
|
Presenter(s):Vicente Riambau, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 1:30 PM - 1:35 PM | DEBATE: Why AAA Screening And Detection Programs Can Be Harmful |
|
Presenter(s):Jes S. Lindholt, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 1:36 PM - 1:41 PM | Impact Of Large Proximal Aortic Necks (> 31 mm) On Midterm EVAR Results: Should Such Patients Be Treated By Ch/EVAR Or F/EVAR |
|
Presenter(s):Ali F. AbuRahma, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 1:42 PM - 1:47 PM | When Can AAAs With Necks > 35 mm In Diameter Be Effectively And Durably Treated By EVAR: Tips And Tricks For Doing So |
|
Presenter(s):Michael J. Singh, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 1:48 PM - 1:53 PM | Current Best Treatment For Secondary Aorto-Enteric Fistulas After Open AAA Repair; After EVAR |
|
Presenter(s):Fabien F.P. Koskas, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 1:54 PM - 2:00 PM | Panel Discussion |
| View Slides in PDF | |
| END OF SESSION 43 | |
| SESSION 44 SCHEDULE | |
|
Wednesday
SESSION 44:
MORE NEW DEVELOPMENTS RELATING TO AAAs AND EVAR
Location: Trianon Ballroom, 3rd Floor
Moderators:Jan D. Blankensteijn, MD / Elliot L. Chaikof, MD, PhD |
|
| x | |
| 2:01 PM - 2:06 PM | Preoperative Exercise Training Prior To AAA Repair: It Improve Outcomes |
|
Presenter(s):Gerard Danjoux, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 2:07 PM - 2:12 PM | What Is The Relationship Between AAA Disease And Cancer: What Are Possible Mechanisms |
|
Presenter(s):Natzi Sakalihasan, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 2:13 PM - 2:18 PM | Increased Risk Of Cancer In EVAR-Treated AAA Patients vs. Those Treated By Open Repair After 8 Years In The EVAR 1 Trial: Is A Practice Change Suggested |
|
Presenter(s):Roger M. Greenhalgh, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 2:19 PM - 2:24 PM | Many AAAs With A Stable Diameter After EVAR Actually Grow In Volume: What Are The Implications And How Should Volume Be Determined Without CT Scans |
|
Presenter(s):Henrik Sillesen, MD, DMSc Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 2:25 PM - 2:30 PM | Surveillance Compliance After EVAR: Non-Compliance Is Associated With Worse Outcomes: What Can Improve Compliance |
|
Presenter(s):Keith D. Calligaro, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 2:31 PM - 2:36 PM | AAA Sac Filling: How Does This New Treatment Modality Work: Technique And Early Results |
|
Presenter(s):Michael J. Jacobs, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 2:37 PM - 2:42 PM | Why Women Are Underrepresented In EVAR Trials And Why They Have Worse Outcomes Than Men With AAA Repair: Why The OVATION And Other New Devices Can Improve EVAR Outcomes In Women |
|
Presenter(s):Martin Storck, MD, PhD / Giovanni Pratesi, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 2:43 PM - 2:48 PM | Mechanism And Prevention Of Abdominal Incision Dehiscence After Open AAA Repair: Why Is It A Worse Problem Than After Open Aorto-Bifemoral Bypass For Occlusive Disease |
|
Presenter(s):Eric Allaire, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 2:49 PM - 2:54 PM | Tips And Tricks For EVAR Treatment Of AAAs With Small Distal Aortic Necks To Avoid Limb Thrombosis |
|
Presenter(s):Rocco Giudice, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 2:55 PM - 3:00 PM | Fibrin Glue Sac Embolization To Allow Safe Durable (10 Years) Standard EVAR For AAAs With Shorter More Challenging Proximal Necks: Technique And Results |
|
Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 3:01 PM - 3:06 PM | AFX Unibody Bifurcated Endograft (Endologix) To Treat Patients With TASC D Aorto-Iliac Disease And An AAA: Technical Tips And Results |
|
Presenter(s):Francesco Speziale, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 3:07 PM - 3:17 PM | Panel Discussion (Refreshments Available In Back Of Room) |
| END OF SESSION 44 | |
| SESSION 45 SCHEDULE | |
|
Wednesday
SESSION 45:
CHALLENGING RECORDED LIVE CASES AND THOSE EMPLOYING INNOVATIVE AND NEW TECHNIQUES
Location: Trianon Ballroom, 3rd Floor
Moderators:Plinio Rossi, MD / Andrew Holden, MBChB / Fabrizio Fanelli, MD, EBIR / Carlo Setacci, MD / Frank J. Veith, MD |
|
| x | |
| 3:17 PM - 3:27 PM | Changed Workflow With Fusion In A 3 Fenestration FEVAR Case |
|
Presenter(s):Eric L.G. Verhoeven, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 3:27 PM - 3:37 PM | The Use Of A Compliant Balloon To Facilitate EVAR And EVAS Procedures |
|
Presenter(s):Andrew Holden, MBChB Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 3:37 PM - 3:47 PM | Kissing Lithoplasty And DCB For Common Iliac Artery Stenoses |
|
Presenter(s):Fabrizio Fanelli, MD, EBIR Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 3:47 PM - 3:57 PM | Arch Aneurysm Repair With A 3-Branch Endograft |
|
Presenter(s):Stephan Haulon, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 3:57 PM - 4:07 PM | Cracking And Paving Of Extremely Calcified Femoropopliteal Lesions |
|
Presenter(s):Andrej Schmidt, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 4:07 PM - 4:17 PM | How To Perform An Optimal DCB Angioplasty From Anatomy To Function |
|
Presenter(s):Francesco Liistro, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 4:17 PM - 4:27 PM | Below Knee Deep Vein Thrombosis As Part Of Ilio-Femoral DVT: How I Deal With It |
|
Presenter(s):Gerard J. O'Sullivan, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 4:27 PM - 4:37 PM | Panel Discussion |
| END OF SESSION 45 | |
| SESSION 46 SCHEDULE | |
|
Wednesday
SESSION 46:
LINC SESSION: PIONEERING TECHNIQUES IN PERIPHERAL ARTERY INTERVENTIONS WITH RECORDED LIVE CASES
|
|
| x | |
| SUPRAAORTIC | |
| 4:37 PM - 4:45 PM | Latest Device Improvements For Carotid Interventions |
|
Presenter(s):William A. Gray, MD |
|
| View Slides in PDF | |
| 4:45 PM - 5:02 PM | Recorded Case: Recanalization Of A Common Carotid Re-Stenosis With Advanced Filter Protection And Latest Stent Technology |
|
Presenter(s):Andrej Schmidt, MD |
|
| View Slides in PDF | |
| FEMORAL | |
| 5:02 PM - 5:10 PM | Advanced Endovascular Techniques For Treating Calcified Lower Extremity CTO Lesions |
|
Presenter(s):Daniela Branzan, MD |
|
| View Slides in PDF | |
| 5:10 PM - 5:27 PM | Recorded Case: Extensive Vessel Prep With Tumescent Anesthesia To Facilitate Stenting Of An Extensively Calcified Lesion |
|
Presenter(s):Andrej Schmidt, MD |
|
| View Slides in PDF | |
| BTK | |
| 5:27 PM - 5:35 PM | Novel Strategies For Drug-Delivery And Scaffolding For Treating Lesions In BTK Arteries |
|
Presenter(s):Marianne Brodmann, MD |
|
| View Slides in PDF | |
| 5:35 PM - 5:52 PM | Recorded Case: BTK Recanalization Wtih Deep Adventitial Drug Delivery And Tack Scaffolding |
|
Presenter(s):Andrej Schmidt, MD |
|
| View Slides in PDF | |
| 5:52 PM - 5:57 PM | Discussion End of Program G |
| END OF SESSION 46 | |